Table:
begin	end	state
1	19	cytoplasmic
20	38	transmembrane
39	57	non-cytoplasmic
58	77	transmembrane
78	96	cytoplasmic
97	116	transmembrane
117	148	non-cytoplasmic
149	170	transmembrane
171	197	cytoplasmic
198	221	transmembrane
222	236	non-cytoplasmic
237	259	transmembrane
260	270	cytoplasmic
271	299	transmembrane
300	323	non-cytoplasmic
324	346	transmembrane
347	357	cytoplasmic
358	382	transmembrane
383	413	non-cytoplasmic
414	433	transmembrane
434	453	cytoplasmic
454	475	transmembrane
476	482	non-cytoplasmic
483	504	transmembrane
505	514	cytoplasmic

Input:
>GFF3740
MSETSMETTPQESRINKPLFLLSGGFIALFCVAALVNLDGLSALVDWGFNIAATYFGLYW
QILLLATFLIGLVLCILPGGRAIMGGLATPEFTTFQWGSMIMCTLLAGGGVFWAAGEPIA
HFLYSPPLYGAEGGSEAAVTPAIAQSFMHWGFLAWAILGSLSTVMLMHYHYEKGLPLAPR
TLLYPVFGDKAINGPIGVIADASSIIAVVAGTVGPIGFLGLQVSYGLSDLFGIPDVFATQ
FVVIGALVALYTISAMTGLSRGIQLLSKINVILAAVLLIYVLLAGPTGFIFGSFFSGFAT
YLGNFFQMALYRGDAAVFGAPGWLGWWTVFFWGWFMGYGPLMAMFIARVSRGRSIRSIII
MLSIIAPIVTNFWFTIIGGTGIAMELAEPGTVSAAFEGFNLPAALLAITNNLPMGFLVSI
LFLILTTIFVATTGDSMSYVISATMTKGDTPSTAVRVFWGIAMGVMAVILISVGSGGVSK
LQSFIVVTAVPVSLILLPSLWDALRITLAKGKES

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server